Pulsion Medical signs licence agreement with BMEYE

Medical Company Product News

Pulsion Medical has confirmed details of a new agreement to integrate technology from BMEYE into its PulsioFlex hemodynamic patient monitoring system.

The non-exclusive worldwide licence will enable the Munich-based firm to provide continuous and non-invasive monitoring of a patient's blood pressure and cardiac output.

With BMEYE's cardiovascular technology, the PulsioFlex will use a finger cuff to measure beat-to-beat and allow detailed hemodynamic monitoring without the risk of vascular cannulation and catheter-related infection.

Patricio Lacalle, chief executive of Pulsion Medical, described the agreement with BMEYE as "another important step in building a consistent product portfolio to monitor patients".

He said the PulsioFlex system will provide "a flexible solution for hospitals by covering non-invasive and minimally invasive hemodynamic monitoring".

Designed for emergency departments and operating rooms, PulsioFlex is a smaller operating system than Pulsion Medical's PiCCO2 product, which includes features such as bedside pulmonary edema assessment and liver function measurement in real time.

See all the latest jobs in Medical Devices
Return to news

Tags